NeuroPace (NPCE) Earnings Analysis

NeuroPace (NPCE) next reports earnings on 2026-08-11, consensus EPS -0.19 USD. Last quarter (2026-03-03) it beat with EPS -0.08 USD vs -0.14 USD est (+42.9%). It has beaten estimates in 2/2 recent quarters (100%). Trailing P/E -22.37.

Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades

When does NPCE next report earnings?

Next earnings date2026-08-11
Consensus EPS estimate-0.19 USD
Revenue estimate0.02B

NPCE earnings history — beats and misses

Quarter (report date)EPS actualEPS est.SurpriseResult
2026-03-03-0.08 USD-0.14 USD+42.9%Beat
2025-03-04-0.18 USD-0.25 USD+28%Beat

Beat rate: 2/2 (100%) over reported quarters with consensus data.

NPCE valuation and analyst view

Trailing P/E-22.37
Trailing EPS-0.63959 USD
Price / book34.01
Dividend yield0.00%
Market cap0.51B
Analyst consensusBuy (9 buy / 1 hold / 0 sell)
Avg price target21 USD

Related research pages

Frequently asked questions

When is NeuroPace (NPCE)'s next earnings date?

NeuroPace is next scheduled to report on 2026-08-11, with a consensus EPS estimate of -0.19 USD and revenue estimate of 0.02B.

Did NPCE beat earnings last quarter?

In its 2026-03-03 report, NPCE posted EPS of -0.08 USD versus a -0.14 USD estimate — a beat of 42.9%.

What is NPCE's earnings track record?

Over the last 2 reported quarters with consensus data, NPCE beat estimates 2 times (100%).

What is NPCE's current P/E ratio and EPS?

NPCE trades at a trailing P/E of -22.37 on trailing EPS of -0.6395918855082774 USD.

What do analysts rate NPCE?

Analyst consensus is "Buy" across 10 ratings (0 strong buy, 9 buy, 1 hold, 0 sell, 0 strong sell). Average 12-month price target: 21 USD.